What is PCOS?

What is PCOS?

Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.

At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.

So, how can the PCOS Association help?

We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.

Here’s what you’ll find at PCOSA:

  • Reliable, science-backed information about what PCOS is (and isn’t)

  • 💬 Supportive communities of people who understand exactly what you’re going through

  • 🧬 Resources for navigating fertility, metabolic health, nutrition, and more

  • 🧠 Education for providers who want to better support their PCOS patients

  • 🙋‍♀️ Advocacy to make sure PCOS is recognized, researched, and respected

No fluff. No fad cures. Just real support, grounded in evidence and compassion.

At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.

pcos

pcos: Latest results from PubMed

Comparison of Long-Term and Stimulated Cycle Protocols in Frozen Embryo Transfer Cycles in Women with Polycystic Ovary Syndrome: A Non-Randomized Clinical Trial

CONCLUSION: Although the long-term protocol showed higher clinical pregnancy rates in unadjusted analyses, after adjusting for confounders, protocol type was not independently associated with clinical pregnancy. Larger randomized trials are needed to confirm these findings, and adverse outcomes should be assessed in future studies.

Published on: Fri, 13 Mar 2026 06:00:00 -0400

Authors: Shamim Pilevari, Mahnaz Yavangi, Zakieh Yarahmadi, Elahe Talebi Ghane,

Burden and projections of polycystic ovarian syndrome in the belt and road countries from 1990 to 2021 in the framework of predictive, preventive, and personalised medicine: Analysis based on the global burden of disease

Guided by the paradigm of predictive, preventive, and personalized medicine (PPPM/3PM), this study systematically evaluated the epidemiological burden of Polycystic ovarian syndrome (PCOS) and its future trends in countries along the Belt and Road Initiative (BRI). Utilizing data from the Global Burden of Disease Study, we applied Joinpoint regression, Net Drift analysis, age-period-cohort (APC) modeling, and Bayesian APC forecasting. Findings indicated a persistent upward trend in PCOS burden...

Published on: Fri, 13 Mar 2026 06:00:00 -0400

Authors: Xin Xin, Yixuan Wang, Jiaxi Li, Pengpeng Liang,

Systems-level actions of luteolin in female reproductive disorders: from molecular mechanisms to clinical translation

Female reproductive disorders represent a major global health challenge. Despite their clinical heterogeneity, these conditions share core pathological mechanisms including oxidative stress, chronic inflammation, hormonal imbalance, metabolic dysfunction, extracellular matrix remodeling, and dysregulated cell survival. Current therapies rarely target these interconnected processes, underscoring the need for multi-pathway modulators. Luteolin, a dietary flavone, has emerged as a promising...

Published on: Fri, 13 Mar 2026 06:00:00 -0400

Authors: Lenah S Binmahfouz,

Extended Oral Glucose Tolerance Test Unmasks Intermediate Metabolic Phenotypes in Polycystic Ovary Syndrome

CONCLUSION: An extended OGTT reveals two prevalent yet distinct early glycemic phenotypes in PCOS, suggesting heterogeneous pathophysiological pathways that may inform dynamic, phenotype-stratified assessment for risk stratification and targeted intervention. However, clinical implementation requires validation through prospective studies.

Published on: Fri, 13 Mar 2026 06:00:00 -0400

Authors: Sanhu Wang, Xiqiang Gao, Fuxing Li,

Optimising metformin use in polycystic ovary syndrome (MET-PCOS): study protocol for a double-blind randomised controlled trial

INTRODUCTION: Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorders globally, affecting 11-13% of women during reproductive age. PCOS is associated with an elevated risk of reproductive, metabolic, endocrine and mental health features. While lifestyle changes are first-line treatment for managing PCOS, metformin is often recommended for individuals with a body mass index (BMI) ≥25 kg/m². The aim of the metformin use in polycystic ovary syndrome (MET-PCOS) trial is to...

Published on: Thu, 12 Mar 2026 06:00:00 -0400

Authors: Hanna-Mari Hautamäki, Hanna Savolainen-Peltonen, Kristiina Rönö, Johanna Melin,

The Spectrum of Serum Prolactin Levels in Patients with Non-Functioning Sellar Masses: A Retrospective Analysis

CONCLUSION: In patients with non-functioning sellar masses, serum prolactin levels rarely exceed 70 ng/ml. This threshold may serve as a useful diagnostic marker to distinguish stalk effect from prolactinomas. Prospective validation in larger cohorts is warranted.

Published on: Thu, 12 Mar 2026 06:00:00 -0400

Authors: Somdatta Giri, Varun Suryadevara, Andi Sadayandi Ramesh, Debasis Gochhait, Krishnan Nagarajan, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Dukhabandhu Naik, Samim A Mondal,

IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a metabolic disorder and a major cause of infertility, affecting approximately 5-18% of women of reproductive age worldwide. Emerging evidence suggests that intrinsic endometrial defects play a critical role in PCOS-associated infertility; however, the underlying molecular mechanisms remain poorly understood. In this study, we demonstrated that interleukin 22 (IL-22) signaling directly modulated endometrial function and that downregulation of the IL-22-STAT3...

Published on: Thu, 12 Mar 2026 06:00:00 -0400

Authors: Baoying Liao, Chuyu Yun, Hongying Shan, Yuqian Wang, Xiunan Chen, Weisi Lian, Tianliu Peng, Min Zhao, Xunsi Qin, Kailun Hu, Ping Zhou, Yue Wang, Yanli Pang, Rong Li,

Expression and significance of ependymin-related protein 1 and neuregulin 4 in the serum of patients with polycystic ovary syndrome

CONCLUSION: Serum levels of EPDR1 and NRG4 were significantly decreased in PCOS patients and showed significant correlations with key metabolic and endocrine parameters (BMI, T, HOMA-IR, LH/FSH ratio, and lipid profiles). These findings highlight their potential value as diagnostic biomarkers for PCOS, reflecting the associated metabolic disturbances.

Published on: Thu, 12 Mar 2026 06:00:00 -0400

Authors: Ren Xiaopang, Song Jie, Hao Wanjiao, Liu Man,

Efficacy and safety of Shatavari root extract in women with Polycystic Ovarian Syndrome: a randomized, double-blind, placebo-controlled trial

CONCLUSION: Shatavari root extract oral administration can be a safe and effective potential intervention for women with PCOS. The study was registered with the Clinical Trials Registry of India (CTRI) under registration number CTRI/2024/10/074660 on October 3, 2024.

Published on: Thu, 12 Mar 2026 06:00:00 -0400

Authors: Yashodhara Mhatre, Pradeep Jadhav, Adwait Malik, Mayakalyani Srivathsan, Deepak Langade,

Obesity and female reproductive health in Asian population

CONCLUSION: Obesity has significant negative effects on female reproductive health from adolescence to menopause but these issues can be reversed with effective weight management. With the increasing rate of obesity in Asia, healthcare professionals must prioritize weight management strategies to mitigate its harmful impact on women's reproductive health.

Published on: Thu, 12 Mar 2026 06:00:00 -0400

Authors: Krasean Panyakhamlerd, Areepan Sophonsritsuk, Tawiwan Pantasri, Ammarin Suwan, Nuttanun Panyawongudom, Parinya Samakkarnthai,

Tet methylcytosine dioxygenase 2(TET2)-dependent epigenetic regulation in the pathogenesis of polycystic ovary syndrome

No abstract

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Kailu Liu, Yanli Hong, Qian Gao, Jingyu Huang, Li Liu, Yueyi Li, Yunteng Liang, Shuxuan Zhang, Xi He, Xiaowei Nie,

Evaluation of autonomic dysfunction with dynamic pupillometry in non-obese young women with polycystic ovary syndrome

CONCLUSION: Newly diagnosed non-obese women with polycystic ovary syndrome exhibit significant alterations in pupillary dynamics, suggesting a generalized reduction in both sympathetic and parasympathetic activity. Dynamic pupillometry may represent a practical, noninvasive tool for detecting early autonomic hypoactivity and identifying patients at risk for future metabolic or cardiovascular complications.

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Kübra Gündogan, Ali Osman Gündogan, Emine Türen Demir, Naciye Tora,

Live Births Following IVF-FET in Two Adult Sisters with Nonclassic P450 Oxidoreductase Deficiency: A Case Report Identifying a Novel POR Variant

CONCLUSION: These cases represent the first report of two siblings with nonclassic PORD achieving live births through IVF-FET. Moreover, we identified a previously unreported POR variant, c.1952_1966del, p.Gly651_His655del, which expands the known mutational spectrum of PORD in the Chinese population. Our findings highlight the importance of early genetic testing in women with atypical infertility, recognition of the distinctive hormonal profile of PORD, and the value of glucocorticoid-supported...

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Yichang Tian, Yan Pei, Ying Fang, Xiaokui Yang, Yu Liang,

Study of association between serum anti-Müllerian hormone, glucose intolerance, and metabolic syndrome in women with polycystic ovarian syndrome: A comparative study

CONCLUSION: Serum AMH is significantly elevated in women with PCOS and is as a potential marker for predicting metabolic risk but has no association with glucose intolerance in PCOS patients.

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Namrata Anand Kondaguli, Pavanaganga A,

Ovulatory Recovery following weight loss in women with polycystic ovary syndrome and obesity: a post hoc analysis of the BAMBINI randomised controlled trial

STUDY QUESTION: What is the frequency of ovulatory recovery (OvR) after different degrees of total weight loss (TWL) in women with polycystic ovary syndrome (PCOS) and obesity, and can an excessive degree of TWL be identified that is harmful to the chance of OvR?

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Suhaniya N S Samarasinghe, Ali Abbara, Patricia M Ortega, Ahmed R Ahmed, Christos Tsironis, Sanjay Purkayastha, Vinod Menon, Harpal Randeva, Alexander D Miras,